At Viralgen, we’re all-in on AAV; in fact, that’s all we do. It’s made us a world leader in AAV-based gene therapy manufacturing, built on a foundation of unmatched expertise and the world’s largest manufacturing capacity dedicated solely to AAV. Our clients get worry-free manufacturing through our Aava™ platform, which we engineered from the start to provide them with better predictability, superior speed and deeper data. More than 60 clients have relied on our team to deliver – and we have, time and again, through 30 AAV serotypes, 2,000+ AAV batches and a 100% success rate for IND/IMPD dossiers.